OFIX
Orthofix Medical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 2
Consensus Rating "Buy"
MACD Death Cross
Bearish Engulfing
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OFIX
Orthofix Medical Inc.
A global medical device company with a spine and orthopedics focus
Healthcare Equipment and Supplies
10/19/1987
04/24/1992
NASDAQ Stock Exchange
1,616
12-31
Common stock
3451 Plano Parkway, Lewisville, Texas 75056
--
Orthofix Medical Inc., is a limited liability company organized under the laws of Guraçao. The company was established on October 19, 1987 under the laws of the Netherlands Antilles. The company is a leading global spine and orthopedics company with a comprehensive biologics portfolio, innovative spine hardware, bone growth therapies, specialized orthopedic solutions, and leading surgical navigation systems. The company's products are designed to replace bones for life and meet the joint replacement needs of patients of all ages, helping to achieve more active mobility. The company designs, develops, produces and sells musculoskeletal medical devices primarily for plastic surgery.
Company Financials
EPS
OFIX has released its 2025 Q1 earnings. EPS was reported at -1.35, versus the expected -0.27, missing expectations. The chart below visualizes how OFIX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
OFIX has released its 2025 Q1 earnings report, with revenue of 193.65M, reflecting a YoY change of 2.67%, and net profit of -53.09M, showing a YoY change of -47.40%. The Sankey diagram below clearly presents OFIX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
